| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 44,9 M € | -12.8% | 51,5 M € | -7.8% | 55,9 M € | +22.3% | 45,7 M € | +57.6% | 29,0 M € | -19.0% | 35,8 M € | +2.1% | 35,0 M € | +4.3% | 33,6 M € | -1.8% | 34,2 M € | -1.1% | 34,6 M € | +8.3% | 31,9 M € | +0.1% | 31,9 M € | -7.6% | 34,5 M € | +9.2% | 31,6 M € | -1.6% | 32,2 M € | +7.7% | 29,8 M € | -1.5% | 30,3 M € | |
| EBITDA | 1,9 M € | -48.0% | 3,7 M € | -14.7% | 4,3 M € | -78.9% | 20,4 M € | +1343.8% | -1,6 M € | -122.5% | 7,3 M € | +117.9% | 3,4 M € | -16.2% | 4,0 M € | -8.2% | 4,4 M € | +73.8% | 2,5 M € | -26.4% | 3,4 M € | +15.0% | 3,0 M € | -34.0% | 4,5 M € | -0.5% | 4,5 M € | -12.8% | 5,2 M € | +28.2% | 4,0 M € | -16.0% | 4,8 M € | |
| Operating profit | 254,6 k € | -90.2% | 2,6 M € | -14.5% | 3,0 M € | -83.6% | 18,6 M € | +610.2% | -3,6 M € | -179.9% | 4,6 M € | +1260.4% | 335,0 k € | -79.0% | 1,6 M € | -3.8% | 1,7 M € | +225.8% | 510,1 k € | -75.2% | 2,1 M € | +52.3% | 1,4 M € | -56.0% | 3,1 M € | +12.1% | 2,7 M € | -21.0% | 3,5 M € | +74.6% | 2,0 M € | -44.1% | 3,5 M € | |
| Profit/loss | 122,8 k € | -93.9% | 2,0 M € | -15.4% | 2,4 M € | -85.2% | 15,9 M € | +529.2% | -3,7 M € | -223.9% | 3,0 M € | +15061.7% | 19,8 k € | -98.1% | 1,0 M € | -15.9% | 1,2 M € | +360.0% | 267,6 k € | -78.1% | 1,2 M € | +28.9% | 949,6 k € | -50.3% | 1,9 M € | +6.7% | 1,8 M € | -23.5% | 2,3 M € | +74.2% | 1,3 M € | -44.0% | 2,4 M € | |
| Equity | 25,6 M € | +0.5% | 25,4 M € | +8.5% | 23,4 M € | +11.2% | 21,1 M € | +309.4% | 5,1 M € | -34.7% | 7,9 M € | +14.3% | 6,9 M € | -6.5% | 7,4 M € | -5.9% | 7,8 M € | -46.3% | 14,6 M € | -3.5% | 15,2 M € | -42.2% | 26,2 M € | -6.0% | 27,9 M € | -2.8% | 28,7 M € | -6.3% | 30,7 M € | -9.3% | 33,8 M € | +1.8% | 33,2 M € | |
| Total assets | 50,8 M € | -1.6% | 51,6 M € | +3.5% | 49,9 M € | +2.4% | 48,7 M € | +25.6% | 38,8 M € | +13.0% | 34,3 M € | -1.8% | 34,9 M € | -5.2% | 36,8 M € | -3.3% | 38,1 M € | +7.5% | 35,4 M € | +21.6% | 29,2 M € | -37.7% | 46,8 M € | +3.1% | 45,3 M € | +4.8% | 43,3 M € | -1.7% | 44,0 M € | -1.1% | 44,5 M € | -0.7% | 44,8 M € | |
| Cash | 3,8 M € | +58.8% | 2,4 M € | -11.8% | 2,7 M € | +590.6% | 396,7 k € | +6.8% | 371,3 k € | -58.3% | 890,8 k € | +19.5% | 745,3 k € | -29.0% | 1,1 M € | +17.3% | 895,6 k € | -60.4% | 2,3 M € | +103.7% | 1,1 M € | +37.9% | 804,5 k € | +29.0% | 623,7 k € | +0.1% | 623,0 k € | +14.7% | 543,0 k € | -52.6% | 1,1 M € | +143.2% | 470,8 k € | |
| Debts | 23,2 M € | -3.4% | 24,0 M € | -1.4% | 24,4 M € | -6.5% | 26,1 M € | -17.4% | 31,5 M € | +27.1% | 24,8 M € | -9.1% | 27,3 M € | -4.5% | 28,6 M € | -4.3% | 29,9 M € | +46.6% | 20,4 M € | +50.6% | 13,5 M € | -32.3% | 20,0 M € | +31.8% | 15,2 M € | +23.2% | 12,3 M € | +10.8% | 11,1 M € | +26.9% | 8,8 M € | -10.3% | 9,8 M € | |
| Staff | 186,1 | 194,8 | 193,1 | 169,6 | 173 | 172,6 | 168,4 | 166,4 | 162 | 164,5 | 163 | 168,5 | 175 | 170,2 | 166,4 | 163,7 | 162,2 | |||||||||||||||||
Public limited company · Bornem · incorporated on 02/03/1958 · 186,1 ETP
Public limited company profitable and well capitalised. Cash position rising (+58.8%).
Solid counterparty for a standard engagement.
LABORATORIA QUALIPHAR is a Public limited company incorporated in 1958. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Bornem. It employs on average 186,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette